Magnus Medical, Inc. — Form D
Magnus Medical, Inc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-14. The offering totals $59.0M, of which $40.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-14
- Form: D
- Accession: 0002057312-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $59.0M
- Amount sold: $40.3M
- Remaining: $18.7M
- Investors: 10
- Date of first sale: 2025-02-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-541012
Issuer
- Name: Magnus Medical, Inc.
- CIK: 0002057312
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1350 OLD BAYSHORE HWY, SUITE 600 1350 Old Bayshore Highway, Suite 600, BURLINGAME, CA, 94010
- Phone: (415) 231-7407
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Xingjuan Chao | Director | Burlingame, CA |
| Nolan Williams | Director | Burlingame, CA |
| Andrew Firlik | Director | Rowayton, CT |
| Andrew Firlik | Related Person | Rowayton, CT |
| Brandon Bentzley | Director | Burlingame, CA |
| Brandon Bentzley | Related Person | Burlingame, CA |
| Vikram Lamba | Executive Officer | Boston, MA |
| Heath Lukatch | Director | Burlingame, CA |
| Heath Lukatch | Related Person | Burlingame, CA |
| Christian Gormsen | Director | Burlingame, CA |
| Christian Gormsen | Executive Officer | Burlingame, CA |
| Achal Achrol | Related Person | Burlingame, CA |
Other filings by this issuer (2)
More